Nov 14, 2018
40 Views

October 15, 2018 Regulatory Developments

Written by


Here are the most recent health care related regulatory developments as published in the New Jersey Register on October 15, 2018:

  • On October 15, 2018, at 50 N.J.R. 2138(a), the Department of Law and Public Safety. Division of Consumer Affairs, proposed new rules and amendments to the rules for the Prescription Monitoring Program (PMP) (N.J.S.A. 45:1-45 et seq.), to expand delegate access to include athletic trainers and medical scribes employed by a hospital’s emergency department, modifies the conditions under which a prescriber is required to look up a patient’s PMP records, and provides for electronic health systems to access prescription monitoring information, so that PMP information can be directly integrated into electronic medical records, making access more user friendly.
  • On October 15, 2018, 50 N.J.R 2150(a), published a recodification of N.J.A.C. 13:49 as N.J.A.C. 8:70.   The Office of the Chief State Medical Examiner (Office) was created as an independent agency within the Department of Health. All functions, powers, and duties of the Office of the State Medical Examiner in the Department of Law and Public Safety (OSME) to the new Office and abolished the OSME.
  • On October 15, 2018, 50 N.J.R 2153(a), the Department of Law and Public Safety. Division of Consumer Affairs, Board of Medical Examiners adopted amendments to the requirements for the dispensing of drugs and special limitations applicable to the dispensing of drugs for a fee. (N.J.A.C. 13:35-7.5).
  • On October 15, 2018, 50 N.J.R 2153(b), the Department of Law and Public Safety. Division of Consumer Affairs, Orthotics and Prosthetics Board of Examiners, adopted amendments to the rules governing the scope of practice and licensure rules for orthotists, orthotist assistants, prosthetists, prosthetist assistants. (N.J.A.C. 13:44H-2.1, 2.2, and 3.5)
  • On October 15, 2018, 50 N.J.R 2177(a), the Department of Health received a petition for rulemaking from Laura I. Thevenot, Chief Executive Officer, American Society for Radiation Oncology (ASTRO), Arlington, Virginia, requesting that the Department add ASTRO as an approved accrediting body for radiation oncology.



Source link

Article Categories:
State Regulatory Developments

Leave a Comment

Your email address will not be published. Required fields are marked *